Red tape could suffocate European clinical trials

October 22, 2003

New measures intended to improve the competitiveness of clinical trials in Europe could have the opposite effect, a leading research …

BMS schizophrenia drug wins US approval

October 22, 2003

New atypical antipsychotic Abilify has gained FDA approval for the treatment of schizophrenia and is tipped to eventually become a …

National service framework leaders appointed

October 22, 2003

Key appointments for the Children's National Service Framework and the Long-term Conditions National Service Framework have been announced.The external working …

Government presses on with MCA merger

October 22, 2003

The UK Government is to press ahead with the merger of the Medicines Control Agency and its medical devices counterpart …

Bayer parallel import case reopened

October 22, 2003

A landmark legal battle over parallel trade of Bayer's blood pressure treatment Adalat has been re-commenced in the European Court …

New Bextra warnings add to COX-II doubts

October 22, 2003

New warnings on the label of second-generation COX-II inhibitor Bextra have added to doubts about the safety of the drug …

Pharmacia man tipped to head Celltech

October 22, 2003

Pharmacia's Head of Research and Development, Goran Ando, is tipped to become Celltech's new Chief Executive when its current incumbent …

Pharma marketing’s changing skills set

October 21, 2003
Business Services, Sales and Marketing marketing, recruitment, skills

Sales and marketing are undergoing something of a revolution as the pharmaceutical industry reacts to a multitude of challenges. Waning …

New FDA head promises improvements for workforce

October 21, 2003

The new FDA Commissioner, Dr Mark McClellan, has pledged that improvements in the working lives of staff will be a …

WTO close to agreeing medicines supply deal

October 21, 2003

World Trade Organisation ministers say they are close to striking a deal aimed at improving the provision of medicines to …

Local people to control foundation hospitals

October 21, 2003

Local people are to play a major role in deciding how the new, more autonomous foundation hospitals are to be …

‘Smart’ cancer drugs share top honours in drug innovation prize

October 21, 2003
prix galien

The innovative science behind two breakthrough cancer drugs, Novartis’ leukaemia treatment Glivec and Roche’s breast cancer drug Herceptin, has been …

NHS palliative care gets

October 21, 2003

Novartis questions AstraZeneca cancer data

October 21, 2003

Novartis has questioned the evidence behind a UK licence extension to AstraZeneca breast cancer drug Arimidex.The Medicines Control Agency licence …

Kogan steps down from troubled Schering

October 21, 2003

Richard Jay Kogan has stepped down as Chairman of Schering-Plough and will relinquish his post as Chief Executive and President …

Latest content